ICF International Inc. (ICFI) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$95.84 +1.25% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $96.29

ICF International Inc. (ICFI) earns a Roarable Rating of B (Buy) with 73/100 RQD Confidence. High-quality cash engine (37% profit margin, 8% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B • BUY Cap $1.72B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ICFI Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is ICFI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-02, ICF International Inc. (NASDAQ: ICFI) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 73/100 at a spot price of $95.84 (+1.25% 1D, market cap $1.72B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 16/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 16/20. Across 1011 tracked Consumer Discretionary issuers, ICFI ranks #94 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does ICFI compare to NSP and ASTH in the Consumer Discretionary sector?
▼

Within the Consumer Discretionary sector (Professional Services), ICFI carries a Roarable B (73/100 RQD), trailing P/E of 18.7x, gross margin of 37.2%, and ROIC of 8.1%. By comparison, NSP (Insperity Inc.) holds a E grade (28/100 RQD, P/E N/A, ROIC -8.9%, cap $1.77B) and ASTH (Astrana Health Inc.) posts a D+ grade (57/100 RQD, P/E 75.7x, ROIC 4.6%, cap $1.82B). Among the 5-stock peer group, EFOR leads on earnings multiple (13.4x) while ICFI leads on capital efficiency (8.1% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ICFI?
▼

Per ICFI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001362004), ICF International Inc. generated $1.87B in revenue (-7.3% YoY), $92.0M in net income, and $141.9M in free cash flow against $2.05B in total assets and $401.4M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $96.28 (+0.46%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 13/20 (C) • 7.6% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 73/100 (B) historically ranked in the Top 13% of excess returns over the next 90 days (+7.1% avg 90D alpha vs SPY • 69.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERBUY • B
025507510073
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk B-
Cash (13)Whales (16)SEC (13)Macro (15)CEO (16)
Each axis scored 0–20
12M PRICE TARGET CONE+6.8% Base Target
$121 Bull$102 Base$79 Bear
📬 FREE ICFI RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ICFI)Realized 20D OHLCV Swing Band: ±5.9%
Deterministic 5-Pillar Attribution (73/100 Composite)
🔍 WHY ICFI SCORES 73/100 (B) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+16/20 pts (22% of score)

20D Institutional Volume Accumulation (±5.9% realized swing band)

▲ #2 Bullish Driver: Insider Conviction & Share Dilution+16/20 pts (22% of score)

SEC Form 4 / 13F Thermometer: 80% Net Buy • Cannibal Buyback (-2.36% YoY Shares)

▼ #1 Drag / Risk Factor: SEC 10-K Forensic Risk13/20 pts (-7 pt drag)

Balance-sheet & 10-K footnote risk deducts 7 pts from forensic ceiling

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
65
Grade C+$87.73+0.8% Next Q
Q2 (-2Q)
68
Grade B-$88.46+8% Next Q
Q3 (-1Q)
70
Grade B$95.54+0.3% Next Q
Current
73
Grade B$95.84+7.1% Hist 90D α
Trajectory: C+ (65) → B (73)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the ICFI Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 73/100 (B) score, ICFI faces multiple-compression risk if 18.7x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) — any gross margin slip below 34.7% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($87.97) or 200D SMA ($78.83) invalidates the momentum regime and cuts Target Base ($102.31) toward Bear Floor ($78.59).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ICFI• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ICFI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

ICFI Smart-Money Thermometer: HEAVY INSIDER & 13F ACCUMULATION

Explore All 13F & Congress Whales →
▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (ICFI)

No recent open-market Form 4 cluster sales or emergency dumps flagged on ICFI. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (ICFI Tape Review)

  • ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
  • ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ICFI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +30.54%▲ ASCENDING CHANNEL
2026-11-02O $94.66H $95.84L $94.66C $95.84VOL 104.2K
RES: $114.7SUP: $83.39SMA50: $87.97SMA200: $78.83
$100.7$89.36$78.01$66.66$55.31RES $114.7SUP $83.39$95.842026-05-042026-06-172026-08-042026-09-172026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ICFI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
12.0%/yr Implied 5Y Growth

vs. -7.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ICFI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ICFI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ICFI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ICFI)

Consumer Discretionary Rank #94 of 1011 ⚔️ NSP vs ICFI Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (ICFI vs. NSP, ASTH, AMN, EFOR)

Industry: Professional Services (48 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, ICF International Inc. (ICFI) ranks #94 by composite RQD confidence (73/100, grade B) and #437 by equity capitalization ($1.72B). Within this direct 5-issuer industry benchmark cohort, EFOR leads on earnings valuation at 13.4x trailing P/E, while ICFI leads on capital efficiency and profitability with 8.1% ROIC and 37.2% gross margin. ICFI currently leads its immediate peer cohort in composite quantitative strength at 73/100 (B).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
ICFI ACTIVE
ICF International Inc.
B 73/100 18.7x 37.2% 8.1% +1.25% $1.72B Benchmark Subject
NSP
Insperity Inc.
E 28/100 — 13.2% -8.9% -10.38% $1.77B /nsp-vs-icfi →
ASTH
Astrana Health Inc.
D+ 57/100 75.7x — 4.6% -0.14% $1.82B /asth-vs-icfi →
AMN
AMN Healthcare Services Inc
D+ 56/100 — 28.3% -7.2% +0.47% $1.82B /amn-vs-icfi →
EFOR
Everforth Inc.
B- 71/100 13.4x 28.9% 6.5% -4.47% $1.52B /efor-vs-icfi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001362004

In its most recent audited fiscal period (FY2025, filed 2025-12-31), ICF International Inc. (ICFI) reported GAAP revenue of $1.87B (-7.3% vs. FY2024 revenue of $2.02B , and -4.6% cumulative change since FY2023) , GAAP net income of $92.0M, operating cash flow of $141.9M, and free cash flow of $141.9M (-17.3% YoY). On the balance sheet, ICFI closed FY2025 with $2.05B in total assets against $401.4M in total debt (Altman Z-Score: 2.87, Piotroski F-Score: 7/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $1.87B $92.0M $141.9M $141.9M $2.05B $401.4M
FY2024 (FY) 2024-12-31 $2.02B $110.0M $171.5M $171.5M $2.07B $411.7M
FY2023 (FY) 2023-12-31 $1.96B $83.0M $152.4M $152.4M — —

3. ICFI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ICFI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, ICF International Inc. (NASDAQ: ICFI) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 73/100 at a spot price of $95.84 (+1.25% 1D, market cap $1.72B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 16/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 16/20. Across 1011 tracked Consumer Discretionary issuers, ICFI ranks #94 in composite RQD confidence.

How does ICFI compare to NSP and ASTH in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Professional Services), ICFI carries a Roarable B (73/100 RQD), trailing P/E of 18.7x, gross margin of 37.2%, and ROIC of 8.1%. By comparison, NSP (Insperity Inc.) holds a E grade (28/100 RQD, P/E N/A, ROIC -8.9%, cap $1.77B) and ASTH (Astrana Health Inc.) posts a D+ grade (57/100 RQD, P/E 75.7x, ROIC 4.6%, cap $1.82B). Among the 5-stock peer group, EFOR leads on earnings multiple (13.4x) while ICFI leads on capital efficiency (8.1% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ICFI?

Per ICFI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001362004), ICF International Inc. generated $1.87B in revenue (-7.3% YoY), $92.0M in net income, and $141.9M in free cash flow against $2.05B in total assets and $401.4M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ICFI trading relative to its 50-day, 200-day, and 52-week technical levels?

ICFI last traded at $95.84 (+1.25% on volume of 104,183 shares), positioning the stock +8.95% above its 50-day simple moving average ($87.97) and +21.58% above its 200-day simple moving average ($78.83). Across its 52-week range of $58.83 to $98.03, ICFI sits at the 94.4% percentile with a 14-day RSI of 71.4 (OVERBOUGHT (>70)) and an implied next-earnings move of ±5.9% ($90.19 to $101.49).

ICFI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are ICFI insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies ICFI leadership and institutional positioning as: HEAVY INSIDER & 13F ACCUMULATION.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $213.66 -0.80% AAPL $348.91 +1.48% MSFT $530.14 -0.16% TSLA $403.30 -0.23% PLTR $196.42 -0.20% SOFI $17.61 +2.74% IBIT $43.36 -0.94% GLD $355.78 -1.34%